Clinical Research

Dr. Julius Few is an active researcher who has participated as an investigator in clinical trials for FDA approval and has published noted studies both in aesthetic surgery and non-surgical treatments.

The Few Institute is proud to be participating in the following FDA studies:

CBD Study:

A single-center study evaluating the effects of a novel retinol and cannabidiol combination topical on facial skin.

Hiperhidrosis Study:

A study to determine whether the use of ultrasound technology will reduce or eliminate underarm sweating.

Midface Volume Deficit Study:

This is a blinded and randomized study that seeks to determine if the use of a dermal filler can successfully augment the cheeks, as well as offset volume loss that can occur during the natural aging process. The dermal filler is used to not only elevate and support the increased tissue laxity and flatness of the face, but also to replace some of the midface volume that has been lost over the years.

Mesh Study:

A facelift study using a dissolvable surgical mesh to help reinforce soft tissue where weakness exists. The mesh could potentially be replaced by minimal fibrotic tissue that will continue the positive effect of the facelift much longer than the traditional approach.